597 views | 2 years ago
Jeanne Tie, MD, discusses the DYNAMIC trial and areas of unmet needs for minimal residual disease (MRD) to become the standard of care for patients with colorectal cancer. The DYNAMIC trial showed that...
1658 views | 2 years ago
Hear from Jun Xia, PhD and Yusi Fu, PhD, co-directors of the Innovative Genomics & Bioinformatics Core (IGBC) at Creighton University, about their cancer research as well as the people who inspire their...
177237 views | 2 years ago
For twenty years, we’ve empowered you to make life-changing science. Delivered the tools to fuel breakthrough discoveries. And we’re not stopping there. Because we know the next #genomicbreakthroughs,...
766 views | 2 years ago
Eric Duncavage, MD, explains how patients with AML can benefit from whole-genome sequencing testing at diagnosis and after treatment for minimal or measurable residual disease (MRD) assessment. Dr....
973 views | 2 years ago
TruSight™ Oncology 500 HRD* is available now. Enable comprehensive genomic profiling (CGP) with accurate homologous recombination deficiency (HRD) assessment, powered by Myriad Genetics. Hear from customer...
589 views | 2 years ago
TruSight™ Oncology 500 HRD* is available now. Enable comprehensive genomic profiling (CGP) with accurate homologous recombination deficiency (HRD) assessment, powered by Myriad Genetics. Hear from customer...
2248 views | 2 years ago
In this video, we demonstrate how to set up and run DRAGEN TruSight Oncology 500 (TSO500) v1.1.1 analysis on the Illumina® Connected Analytics (ICA) platform. Introducing Illumina Connected Analytics:...
159 views | 2 years ago
Learn how to request a quote extension in MyIllumina, enabling you to better manage your quotes within Order Management. Register or sign in to MyIllumina: https://my.illumina.com View all Illumina...